|
"nakagawa goto k"的相關文件
顯示項目 1-10 / 14 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-07-22 |
Androgen receptor-controlled microRNA-124-3p.2 suppresses prostate cancer progression via CCL2 inhibition
|
Aoyama, S;Izumi, K;Hiratsuka, K;Inaba, T;Koketsu, Y;Nakagawa, R;Toriumi, R;Kamijima, T;Kano, H;Makino, T;Naito, R;Kadomoto, S;Iwamoto, H;Yaegashi, H;Kawaguchi, S;Shigehara, K;Nohara, T;Nakata, H;Saito, Y;Nakagawa-Goto, K;Lin, WJ;Mizokami, A |
| 國家衛生研究院 |
2022-12-07 |
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis
|
Kano, H;Izumi, K;Hiratsuka, K;Toriumi, R;Nakagawa, R;Aoyama, S;Kamijima, T;Shimada, T;Naito, R;Kadomoto, S;Iwamoto, H;Yaegashi, H;Kawaguchi, S;Nohara, T;Shigehara, K;Kadono, Y;Saito, Y;Nakagawa-Goto, K;Yoshioka, K;Nakata, H;Lin, WJ;Mizokami, A |
| 臺大學術典藏 |
2021-06-02T05:43:49Z |
A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways
|
Kuo T.-C.; Chiang P.-C.; Yu C.-C.; Nakagawa-Goto K.; Bastow K.F.; Lee K.-H.; JIH-HWA GUH |
| 臺大學術典藏 |
2020-12-28T05:56:09Z |
A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways
|
Guh J.-H.; Bastow K.F.; Lee K.-H.; Nakagawa-Goto K.; Yu C.-C.; Chiang P.-C.; TING-CHUN KUO |
| 臺大學術典藏 |
2020-12-02T02:34:11Z |
Antitumor agents 283. Further elaboration of Desmosdumotin C analogs as potent antitumor agents: Activation of spindle assembly checkpoint as possible mode of action
|
Nakagawa-Goto K. ;Pan-Chyr Yang Et Al.; Nakagawa-Goto K.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-06-17T03:01:51Z |
Antitumor agents 283. Further elaboration of Desmosdumotin C analogs as potent antitumor agents: Activation of spindle assembly checkpoint as possible mode of action
|
Nakagawa-Goto K. ;Wu P.-C. ;Bastow K.F. ;Yang S.-C. ;Sung-Liang Yu ;Chen H.-Y. ;Lin J.-C. ;Goto M. ;Morris-Natschke S.L. ;Yang P.-C. ;Lee K.-H.; Nakagawa-Goto K.; Wu P.-C.; Bastow K.F.; Yang S.-C.; SUNG-LIANG YU; Chen H.-Y.; Lin J.-C.; Goto M.; Morris-Natschke S.L.; Yang P.-C.; Lee K.-H. |
| 臺大學術典藏 |
2018-09-10T08:30:27Z |
A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways
|
Kuo, T.-C.;Chiang, P.-C.;Yu, C.-C.;Nakagawa-Goto, K.;Bastow, K.F.;Lee, K.-H.;Guh, J.-H.; JIH-HWA GUH |
| 中國醫藥大學 |
2010-03 |
Antitumor Agents. 272. Structure-Activity Relationships and In Vivo Selective Anti-Breast Cancer Activity of Novel Neo-tanshinlactone Analogues.
|
(Dong, Y.); (Shi, Q.); (Pai, H.C.); 彭婕妤(Chieh-Yu Peng); (Pan, S.L.); (Teng, C.M.); (Nakagawa-Goto K,); (Eva Y.-H. P. Lee,#); 李國雄(Lee, K.H.)* |
| 中國醫藥大學 |
2010-02 |
Antitumor Agents. 272. Structure-Activity Relationships and In Vivo Selective Anti-Breast Cancer Activity of Novel Neo-tanshinlactone Analogues
|
(Dong Y); (Shi Q); (Pai HC); (Peng CY); (Pan SL); (Teng CM); (Nakagawa-Goto K); (Yu D); (Liu YN); (Wu PC); (Bastow KF); (Morris-Natschke SL); (Brossi A); (Lang JY); (Hsu JL); 洪明奇(Mien-Chie Hung); (Lee EY); (Lee KH)* |
| 中國醫藥大學 |
2010 |
Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents.
|
(Dong Y,); (Shi Q); (Nakagawa-Goto K,); (Wu PC); (Morris-Natschke SL); (Brossi A,); (Bastow, KF,); (Lang JY); 洪明奇(Mien-Chie Hung); (Lee, KH)* |
顯示項目 1-10 / 14 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
